Shire in advanced talks on acquisitions

Add to My Stories Print page Add to Favourites

Chief executive Flemming Ornskov is understood to have informed investors that the UK pharmaceuticals firm Shire is holding advanced discussions regarding acquisitions. Shire’s share price closed up 13p at 2085p on February…